Skinny-Label Saga Hangs In Balance As Supreme Court Seeks Input
Top US Court Asks Solicitor General For Views Of US On GSK-Teva Case
As the US Supreme Court deliberates on whether to grant Teva’s petition to review its litigation with GSK over “skinny label” generics that carve out patented indications, Aziz Burgy, partner at Axinn, Veltrop & Harkrider LLP, talks to Generics Bulletin about the key issues at stake.
